4P-Pharma is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.
4P-Pharma has raised $16.1M in total funding. The most recent round was Undisclosed. The last funding was announced in April 2024.
4P-Pharma's investors include Eurasante.
4P-Pharma is headquartered in Lille, France.
4P-Pharma is a clinical-stage company that develops regenerating active drugs and therapies to cure untreated serious diseases.
4P-Pharma is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"4P-Pharma — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/4p-pharma. Accessed August 14, 2026.
VCBacked. (2024). 4P-Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/4p-pharma
{{cite web |title=4P-Pharma — Funding & Investors |url=https://www.vcbacked.co/company/4p-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated